From: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma
Group
Trend
Decrease > 50%
Increase > 50%
No change
Total
Response
16
32
40
88
Non-response
2
10
19
31
18
42
59
119
P value
0.187